Author: Carly Behm

Here are six updates from gastroenterology companies and practices from the past week:

St. Cloud (Minn.) Surgical Center broke ground on an $11 million facility expansion, according to an Oct. 13 report from KNSI.

Doylestown (Pa.) Hospital finished a $54 million, 100,000-square-foot addition, according to Healthcare Construction and Operations.

Madison, Wis.-based Exact Sciences introduced the Oncotype MAP Pan-Cancer Tissue test for patients with advanced, metastatic, refractory or recurrent cancer, according to an Oct. 12 press release.

Trine University in Angola, Ind., received recognition for its surgical technology suite, according to an Oct. 12 press release. Here are four details:

Dover, Del.-based Bayhealth is moving forward with plans for a new outpatient center in an Oct. 12 press release.

Johnson City, Tenn.-based Watauga Orthopaedics is looking to build a new ASC near the Tri-Cities Airport in Blountville, Tenn., according to an Oct. 12 report from WJHL.

The University of Minnesota in Minneapolis launched a new clinical trial that will use CRISPR genetic engineering to treat metastatic gastrointestinal solid tumor cancer, according to an Oct. 12 press release.

Lansing, Mich.-based Sparrow Health announced construction of a new outpatient surgery center in an Oct. 12 press release.

Here's what six otolaryngoloists told Becker's ASC Review about their outlook on the field over the next one to two years: